Completed | December 2017

Maternal HIV Seroconversion during the Pregnancy and Breastfeeding Period

Incidence and Associated Risk Factors

Overview

Country:

Mozambique

Subject Matter:

Maternal, Newborn, and Child Health

This Bill & Melinda Gates Foundation-funded prospective cohort study followed two cohorts of HIV-uninfected women—one cohort from antenatal care to delivery and the other from delivery to 18 months postpartum—with serial HIV testing to identify HIV seroincidence in each cohort in Mozambique.

Data Collection Period: April 2008-November 2011

  1. Findings published in the Journal of the International AIDS Society, March 2014: “High HIV incidence in the postpartum period sustains vertical transmission in settings with generalized epidemics: a cohort study in Southern Mozambique“
  2. Findings published in PLOS ONE, December 2014: “High Rates of HIV Seroconversion in Pregnant Women and Low Reported Levels of HIV Testing among Male Partners in Southern Mozambique: Results from a Mixed Methods Study“

Explore Other Research

In Analysis Birth Surveillance in Eswatini Following Transition To Dolutegravir-based Treatment Maternal, Newborn, and Child Health; PMTCT and HIV-free Survival
Completed Knowledge, Attitudes and Practices Related to Oral Pre-exposure Prophylaxis (PrEP) for HIV among Pregnant and Lactating Women in Eswatini Adult Testing, Care, and Treatment; Maternal, Newborn, and Child Health
Ongoing Data Collection Assessment of Birth Outcomes in Eswatini after Transition to Dolutegravir-based Treatment Maternal, Newborn, and Child Health; Pediatric and Adolescent Testing, Care, and Treatment
All Research